Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 26, Issue 5, Pages 225-228Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2005.03.002
Keywords
-
Categories
Funding
- NCI NIH HHS [CA 95094] Funding Source: Medline
- NIDDK NIH HHS [DK 065251] Funding Source: Medline
Ask authors/readers for more resources
Cofactor recruitment is a crucial regulatory step in nuclear receptor signal transduction. Given the obligate nature of interactions between cofactors and these receptors for transcriptional activity, it is likely that drugs that target coactivator interaction surfaces will function as pure antagonists with particular utility in the treatment of estrogen- and androgen-dependent cancers. Recent crystallographic analysis of one of the major protein-protein interaction surfaces on the androgen receptor has raised expectations that it will be possible to develop small-molecule antagonists that block cofactor interactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available